Difference between revisions of "Small cell carcinoma of the urinary bladder"

Jump to navigation Jump to search
no edit summary
(fix loca)
(One intermediate revision by the same user not shown)
Line 8: Line 8:
| Subtypes  =
| Subtypes  =
| LMDDx      = [[small cell carcinoma of the prostate gland]], [[lymphoma]] (large cell), other [[small round blue cell tumours]]
| LMDDx      = [[small cell carcinoma of the prostate gland]], [[lymphoma]] (large cell), other [[small round blue cell tumours]]
| Stains    = pankeratin +ve, chromogranin +ve, synaptophysin +ve, CD56 +ve
| Stains    = [[pankeratin]] +ve, chromogranin +ve, synaptophysin +ve, [[CD56]] +ve
| IHC        =
| IHC        =
| EM        =
| EM        =
Line 33: Line 33:


==General==
==General==
*Very rare.<ref name=pmid24168010>{{Cite journal  | last1 = Koga | first1 = F. | last2 = Yokoyama | first2 = M. | last3 = Fukushima | first3 = H. | title = Small cell carcinoma of the urinary bladder: a contemporary review with a special focus on bladder-sparing treatments. | journal = Expert Rev Anticancer Ther | volume = 13 | issue = 11 | pages = 1269-79 | month = Nov | year = 2013 | doi = 10.1586/14737140.2013.851605 | PMID = 24168010 }}</ref>
*Very rare<ref name=pmid24168010>{{Cite journal  | last1 = Koga | first1 = F. | last2 = Yokoyama | first2 = M. | last3 = Fukushima | first3 = H. | title = Small cell carcinoma of the urinary bladder: a contemporary review with a special focus on bladder-sparing treatments. | journal = Expert Rev Anticancer Ther | volume = 13 | issue = 11 | pages = 1269-79 | month = Nov | year = 2013 | doi = 10.1586/14737140.2013.851605 | PMID = 24168010 }}</ref> - less than 1% of bladder cancers in one series.<ref name=pmid24009428>{{Cite journal  | last1 = Hou | first1 = CP. | last2 = Lin | first2 = YH. | last3 = Chen | first3 = CL. | last4 = Chang | first4 = PL. | last5 = Tsui | first5 = KH. | title = Clinical outcome of primary small cell carcinoma of the urinary bladder. | journal = Onco Targets Ther | volume = 6 | issue =  | pages = 1179-85 | month =  | year = 2013 | doi = 10.2147/OTT.S49879 | PMID = 24009428 }}</ref>
*Poor prognosis.<ref name=pmid24168010/>
*Poor prognosis<ref name=pmid24168010/> - survival ~ 11 months.<ref name=pmid24009428/>
 
Clinical:
*Hematuria - typical presentation.<ref name=pmid24009428/>
 
Epidemiology:
*[[Smoking]] - very common.<ref name=pmid24009428/>


==Microscopic==
==Microscopic==
Features:
Features:
*See ''[[small cell carcinoma]]''.
*See ''[[small cell carcinoma]]''.
Note:
*Usually co-exists with [[urothelial carcinoma]] ~60% of cases in one series.<ref name=pmid24009428/>


DDx:
DDx:
Line 53: Line 62:


==IHC==
==IHC==
*Pankeratin +ve,
*[[Pankerati]]n +ve,
*Chromogranin +ve.
*Chromogranin +ve.
*Synaptophysin +ve.
*Synaptophysin +ve.
*CD56 +ve.
*[[CD56]] +ve.


==See also==
==See also==
48,453

edits

Navigation menu